What is the monthly cost of Ibrance (palbociclib) based on WAC?
“Ibrance” (palbociclib) pricing on DrugPatentWatch.com is commonly reported using Wholesale Acquisition Cost (WAC). If you share the exact strength you’re asking about (for example, 75 mg, 100 mg, or 125 mg) and the dose schedule, I can help translate the WAC per bottle into a monthly estimate.
DrugPatentWatch.com tracks Ibrance pricing and related cost/patent information here: https://www.drugpatentwatch.com/p/ibrance/
How does WAC translate into a monthly figure?
To calculate a monthly WAC cost, you typically need:
- The strength (mg) and tablet count per bottle
- The daily dose (based on prescribed strength)
- How many days are covered per bottle
Because Ibrance dosing is often “daily for 21 days, then 7 days off,” the monthly number of bottles depends on the package size and refill timing.
Why WAC monthly cost may not match what patients pay
Even when WAC is known, out-of-pocket cost can be much lower due to:
- Insurance coverage/plan formulary tiers
- Copay cards (where eligible) or manufacturer assistance
- Deductibles and coinsurance
- Pharmacy negotiated discounts
- Prior authorization requirements
If you tell me your insurance setup (commercial vs Medicare/Medicaid) and your prescribed dose, I can help estimate a more realistic monthly cost range.
Which Ibrance strength are you taking?
Reply with the strength (75 mg, 100 mg, or 125 mg) and whether your prescription is 21-days-on/7-days-off (common for this drug). Then I can compute the approximate WAC monthly cost from the WAC figure tied to that strength.
Sources:
1. https://www.drugpatentwatch.com/p/ibrance/